Old Web
English
Sign In
Acemap
>
authorDetail
>
David H. Gallinson
David H. Gallinson
Bevacizumab
Onartuzumab
Colorectal cancer
Phases of clinical research
Medicine
2
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized, phase II, multicenter, double-blind, placebo-controlled study evaluating onartuzumab (MetMAb) in combination with mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
2017
Journal of Clinical Oncology
Johanna C. Bendell
Thomas J. Ervin
David H. Gallinson
Jaswinder Singh
James Wallace
Mansoor N. Saleh
Marcy Vallone
Stephen Paul Hack
Show All
Source
Cite
Save
Citations (1)
Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer
2013
Clinical Colorectal Cancer
Johanna C. Bendell
Thomas J. Ervin
David H. Gallinson
Jaswinder Singh
James Wallace
Mansoor N. Saleh
Marcy Vallone
See-Chun Phan
Stephen Paul Hack
Show All
Source
Cite
Save
Citations (32)
1